230 related articles for article (PubMed ID: 23718671)
1. [Castleman disease: retrospective single-center study of therapeutic results in 10 patients].
Szturz P; Adam Z; Rehák Z; Koukalová R; Sprláková-Puková A; Michalka J; Smardová L; Volfová P; Lengerová M; Mayer J
Klin Onkol; 2013; 26(2):124-34. PubMed ID: 23718671
[TBL] [Abstract][Full Text] [Related]
2. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
[TBL] [Abstract][Full Text] [Related]
3. [PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review].
Adam Z; Szturz P; Koukalová R; Řehák Z; Pour L; Krejčí M; Šmardová L; Eid M; Volfová P; Čermáková Z; Křen L; Sokol F; Hanke I; Michalková E; Král Z; Mayer J
Vnitr Lek; 2015 Mar; 61(3):251-9. PubMed ID: 25873122
[TBL] [Abstract][Full Text] [Related]
4. [Our experience in treatment of multicentric plasma-cell Castleman disease associated with vasculitis manifestations - case report and literature review].
Szturz P; Adam Z; Moulis M; Smardová L; Klincová M; Slaisová R; Koukalová R; Rehák Z; Volfová P; Chovancová J; Stehlíková O; Mayer J
Vnitr Lek; 2012 Sep; 58(9):679-90. PubMed ID: 23094815
[TBL] [Abstract][Full Text] [Related]
5. FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.
Koukalová R; Selingerová I; Řehák Z; Adam Z; Szturz P
Klin Onkol; 2021; 34(2):120-127. PubMed ID: 33906360
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of 14 cases of Castlemans disease: the experience of one centre and an overview of literature].
Adam Z; Szturz P; Krejčí M; Koukalová R; Michalková E; Řehák Z; Pourová E; Pour L; Volfová P; Sandecká V; Čermáková Z; Křen L; Sokol F; Hanke I; Penka I; Petrášová H; Ševčíková S; Král Z; Mayer J
Vnitr Lek; 2016 Apr; 62(4):287-98. PubMed ID: 27250606
[TBL] [Abstract][Full Text] [Related]
7. Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?
Abid MB; Peck R; Abid MA; Al-Sakkaf W; Zhang Y; Dunnill GS; Staines K; Sequeiros IM; Lowry L
Hematol Oncol; 2018 Feb; 36(1):320-323. PubMed ID: 28401573
[TBL] [Abstract][Full Text] [Related]
8. Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.
Zhou X; Wei J; Lou Y; Xu G; Yang M; Liu H; Mao L; Tong H; Jin J
Front Med; 2017 Jun; 11(2):287-292. PubMed ID: 28367597
[TBL] [Abstract][Full Text] [Related]
9. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.
Bowne WB; Lewis JJ; Filippa DA; Niesvizky R; Brooks AD; Burt ME; Brennan MF
Cancer; 1999 Feb; 85(3):706-17. PubMed ID: 10091744
[TBL] [Abstract][Full Text] [Related]
10. [PET-CT documented fast onset of treatment response to cyclophosphamide, thalidomide and dexamethasone in patients with multicentric Castlemans disease. Case description and treatment information overview].
Adam Z; Szturz P; Křen L; Krejčí M; Pour L; Svoboda T; Hanke I; Penka I; Koukalová R; Rehák Z; Cervinková I; Storková T; Král Z; Mayer J
Vnitr Lek; 2013 Apr; 59(4):301-12. PubMed ID: 23711057
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J
J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902
[TBL] [Abstract][Full Text] [Related]
12. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
[TBL] [Abstract][Full Text] [Related]
13. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
Chronowski GM; Ha CS; Wilder RB; Cabanillas F; Manning J; Cox JD
Cancer; 2001 Aug; 92(3):670-6. PubMed ID: 11505414
[TBL] [Abstract][Full Text] [Related]
14. The Role of Radiation Therapy in Unicentric Castleman Disease: A Case Report.
Rodriguez C; Rivera Rubi L; Menjivar O; Suazo J
Cureus; 2023 Nov; 15(11):e49687. PubMed ID: 38161935
[TBL] [Abstract][Full Text] [Related]
15. Brief communication: rituximab in HIV-associated multicentric Castleman disease.
Bower M; Powles T; Williams S; Davis TN; Atkins M; Montoto S; Orkin C; Webb A; Fisher M; Nelson M; Gazzard B; Stebbing J; Kelleher P
Ann Intern Med; 2007 Dec; 147(12):836-9. PubMed ID: 18087054
[TBL] [Abstract][Full Text] [Related]
16. Castleman Disease.
Wang W; Medeiros LJ
Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
[TBL] [Abstract][Full Text] [Related]
17. Unicentric castleman disease is not clearly distinguished from multicentric type: a case report.
Choi JH; Jo YJ; Gong SJ; Hong BW; Lee HJ; Son BK; Jun DW; Kim SH; Park YS; Seok JW
Clin Lymphoma Myeloma; 2008 Aug; 8(4):256-9. PubMed ID: 18765316
[TBL] [Abstract][Full Text] [Related]
18. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
[TBL] [Abstract][Full Text] [Related]
19. Afebrile Pneumonia in a Patient With Multicentric Castleman Disease on Siltuximab: Infection Without Fever on Anti-Interleukin-6 Therapy.
Cohen PR; Nikanjam M; Kato S; Goodman AM; Kurzrock R
Cureus; 2020 Jul; 12(7):e8967. PubMed ID: 32766009
[TBL] [Abstract][Full Text] [Related]
20. Castleman disease of the hyaline vascular variant transforming to POEMS syndrome as endpoint: a case report.
Ge Y; Da Q; Dai Y
BMC Neurol; 2018 Oct; 18(1):169. PubMed ID: 30301456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]